| Oct 14 |
HeartSciences to Participate in the 2024 Maxim Healthcare Virtual Summit
|
| Sep 24 |
Why Maison Solutions Shares Are Trading Higher By Around 91%; Here Are 20 Stocks Moving Premarket
|
| Sep 12 |
Heart Test Laboratories GAAP EPS of -$2.64 misses by $0.18
|
| Sep 12 |
HeartSciences Provides Business Update and Reports First Quarter Fiscal 2025 Financial Results
|
| Sep 12 |
HeartSciences Closes Non-Dilutive Financing to Increase its Cash Runaway Ahead of Upcoming FDA Submission
|
| Jul 29 |
Heart Test Laboratories reports FY results
|
| Jul 29 |
HeartSciences Provides Business Update and Reports Fiscal 2024 Financial Results
|
| Jul 26 |
Innovation Value Institute Analysis Demonstrates HeartSciences’ MyoVista® wavECG™ Potential to Improve Cardiovascular Pathway Efficiency
|
| Jul 25 |
HeartSciences Selected to Demonstrate MyoVista® wavECG™ at the United Nations General Assembly Digital Health Symposium as a Technology to Radically Transform Healthcare
|
| Jul 11 |
HeartSciences Announces Allowance of U.S Patent for AI-ECG Assessment of Left Ventricular and Right Ventricular Heart Dysfunction
|
